
BPC-157 Peptide
A physician-supervised BPC-157 peptide protocol designed to support the body's natural recovery and tissue repair processes. Programs include an online provider consultation, medication, supplies, and ongoing clinician guidance. Eligibility is determined by a licensed healthcare provider.
You save $99
- Clinician consultation
- Peptide medication
- Free shipping
- May require labs
One-time payment, not a subscription. Up to 3 cycles per year. A cycle is the program length; your provider decides whether treatment is right for you and sets your dose, schedule and duration. We do not offer clinical trials. Individual results may vary.
- 43,000+Patients served
4.8Google rating- US-licensed503A Pharmacies
BPC-157 is studied, mostly in lab and animal research, for a potential role in the body's own tissue-repair and recovery pathways.
Preclinical research has explored BPC-157's potential in musculoskeletal and gastrointestinal recovery.
Licensed providers determine eligibility, dosing, and duration based on medical history and clinical evaluation.
Protocols are structured and time-limited rather than open-ended.
When clinically appropriate, BPC-157 may be coordinated alongside recovery, wellness, or longevity programs.
All treatment plans require medical evaluation and approval. Individual results may vary.
Take control of your health in 6 simple, affordable steps
Personalized Intake
Tell us about your health, goals, and history through a secure intake questionnaire.
Clinician Review
A licensed clinician reviews your information and determines what's right for you.
Diagnostic Lab Testing
Baseline lab work checks your health markers before any peptide is prescribed.
Clinical Evaluation
A provider reviews your labs with you in a live video visit and confirms your suitability for peptide therapy.
Medication Delivered
Your prescribed medication is prepared by a partner pharmacy and shipped to your home.
Ongoing Support
Your progress is monitored with follow-ups and adjustments as needed.
Built around 12-week cycles
Peptide programs are sold in 12-week cycles (about 3 months). You can buy one cycle or a bundle of up to 3 cycles up front, with a maximum of 3 cycles per year.
Labs and a provider consultation are required.
Every peptide program starts with lab work and a live consultation with a licensed provider before anything is prescribed.
- Lab panel includedOne cycle at a time
- Bundle of 2 · save 7.5%
- Bundle of 3 · save 12.5%
- Clinician consultation & follow-up access
- All peptide medication for the cycle
- Shipping to your door
- Injection supplies & dosing guide
Peptide therapy
Not sure which peptide program is right for you?
Talk it through first in a free 15-minute provider consultation. A U.S.-licensed provider will go over your goals and health history, explain how the programs work, and help you decide whether one is right for you before you commit to a cycle. There is no obligation to start treatment.
Book a Free Provider ConsultationUnderstanding BPC-157 and Tissue Repair
Learn how clinician-guided BPC-157 peptide therapy is being studied to support the body's natural recovery and repair processes.
Understanding BPC-157
Learn about BPC-157, how it works, and how clinician-guided therapy may support your recovery goals.
The Physiology
Proposed Repair Pathway
Injury → Angiogenesis + growth-factor signaling → Localized repair
Proposed from animal and lab studies; not confirmed in people.
BPC-157 is a synthetic peptide based on a protective sequence found in gastric juice. In animal and lab studies it has been studied for healing at the site of injury and in the gut lining, for new blood-vessel formation (angiogenesis), and for local inflammation.
In that research its effects were mostly studied near the injury site. How it works in people is still being researched.
Symptoms
Symptoms & Signals
Some individuals report patterns such as:
Experiencing multiple patterns may warrant clinician evaluation.
Who Is It For?
Who May Benefit from BPC-157?
BPC-157 may be considered for adults who are:
Clinical evaluation is required. Your eligibility will be determined by a licensed provider.
BPC-157 vs TB-500
BPC-157 vs TB-500
How the research on each differs. Both are early: mostly animal and lab studies.
BPC-157
Studied mainly for repair at the injury site (animal research).
- Animal studies: tendon, ligament and gut healing
- Effects studied mainly near the injury site
- Human evidence: very limited
TB-500
Studied for body-wide repair (mostly animal research).
- •Animal studies: cell migration and tissue remodeling
- •Studied for broad or hard-to-reach injury
- •Human evidence: very limited
The two are often discussed together as the “Wolverine” pairing. The pairing itself has not been studied.
Treatment decisions are determined through clinician evaluation.
Protocol
Protocol Philosophy
BPC-157 is studied for supporting the body's own repair processes, so any response tends to build gradually.
An example, not your plan. This page offers injectable BPC-157 only; there is no oral form here. The 12-week cycle you choose is the program: clinician consultation, peptide medication and free shipping; labs may be required. It is not a dosing schedule; your provider decides your dose, how often and for how long.
Start (Weeks 1–2)
Injections begin as your provider prescribes, often near the injury site.
Build (Weeks 3–6)
Some people report changes in comfort or mobility. This is not guaranteed.
Review (Weeks 6–12)
Your provider assesses your response and adjusts or stops treatment.
Responses vary by individual.
Research Findings and Limits
Research Findings and Limits
What BPC-157 has been studied for, and the kind of study behind each:
Limits of the research. Most BPC-157 research is preclinical (lab and animal studies). Human evidence is very limited, and no outcome is guaranteed.
Individual responses vary.
Designed for Safety. Guided by Clinicians.
- Not FDA-approved — BPC-157 is compounded, and its availability through compounding is subject to ongoing FDA review
- Much of the research is preclinical — human mechanisms and effects are still being studied, which your provider explains before you consent
- Gradual, not instant — any response builds over weeks and is not guaranteed, with follow-ups to adjust your plan
BPC-157 is screened for contraindications (active or recent cancer, pregnancy and breastfeeding); eligibility, appropriateness and dosing are determined by a licensed provider

Our patients trust us because we combine real medicine with real care.
The licensed providers behind your personalized care
Frequently Asked Questions
Get answers to commonly asked questions.
Yes. BPC-157 requires evaluation by a licensed provider, who determines eligibility before any medication is prescribed.
BPC-157, short for Body Protection Compound 157, is a synthetic peptide based on a sequence found naturally in the digestive tract. It has been studied primarily in preclinical research for tissue repair, recovery, and gut health.
No. BPC-157 is not an FDA-approved drug, and its availability through compounding pharmacies is subject to ongoing FDA review. A licensed provider determines whether it is appropriate for you.
In preclinical studies, BPC-157 has been observed to support healing-related processes such as the formation of new blood vessels and tissue repair. Its mechanisms and effects in humans are still being researched.
BPC-157 has been studied for its potential to support recovery from tendon, ligament, and muscle injuries, as well as gut health. It is not FDA-approved, and any use should be guided by a licensed clinician.
Still have questions? Contact us



















